Aidan Burton

Aidan Burton possesses over 14 years of experience in the pharmaceutical Regulatory Affairs field, demonstrating a strong expertise in obtaining approvals for Marketing Authorisation Applications across Europe, Asia Pacific, the Middle East/Africa, and Latin America, as well as managing subsequent lifecycle maintenance activities. Currently serving as the Director of Regulatory Affairs at G&L Healthcare Advisors since April 2020, Aidan has held various roles including Regulatory Affairs Consultant at Fraxinus Regulatory Services Ltd and multiple titles at Mundipharma Research Limited, showcasing a progression from Senior Regulatory Affairs Manager to Regulatory Affairs CMC Lead. Previous experience includes positions at Napp Pharmaceutical Research Limited and Napp Pharmaceuticals, with foundational education from Aston University.